Ashley Cordova - 02 Dec 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Financial Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for Ashley Cordova
Issuer symbol
NVCR
Transactions as of
02 Dec 2022
Net transactions value
$0
Form type
4
Filing time
05 Dec 2022, 15:33:18 UTC
Previous filing
06 Sep 2022
Next filing
10 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $14,300 +2,000 +2.8% $7.15* 74,376 02 Dec 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $14,300 -2,000 -21% $7.15* 7,752 02 Dec 2022 Ordinary Shares 2,000 $7.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested as of the date hereof.